Weiss Multi-Strategy Advisers’s Insys Therapeutics, Inc. INSY Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-35,000	Closed	-$123K	–	658
2018 Q4	$123K	Hold	35,000	–	–	0.01%	425
2018 Q3	$353K	Sell	35,000 -8,830	-20%	-$70.4K	0.01%	473
2018 Q2	$317K	Buy	43,830 +7,130	+19%	+$49.7K	0.01%	509
2018 Q1	$222K	Buy	36,700 +2,200	+6%	+$18.2K	0.01%	499
2017 Q4	$332K	Hold	34,500	–	–	0.01%	518
2017 Q3	$306K	Sell	34,500 -10,000	-22%	-$103K	0.01%	453
2017 Q2	$563K	Sell	44,500 -500	-1%	-$5.92K	0.02%	426
2017 Q1	$473K	Buy	45,000 +24,000	+114%	+$256K	0.02%	449
2016 Q4	$193K	Hold	21,000	–	–	0.01%	384
2016 Q3	$248K	Sell	21,000 -510	-2%	-$7.75K	0.02%	387
2016 Q2	$278K	Sell	21,510 -8,490	-28%	-$124K	0.02%	357
2016 Q1	$480K	Hold	30,000	–	–	0.02%	391
2015 Q4	$859K	Sell	30,000 -5,000	-14%	-$139K	0.06%	256
2015 Q3	$996K	Sell	35,000 -15,000	-30%	-$552K	0.04%	268
2015 Q2	$1.8M	Sell	50,000 -40,000	-44%	-$1.25M	0.07%	263
2015 Q1	$2.62M	Buy	90,000 +2,000	+2%	+$52.9K	0.12%	215
2014 Q4	$1.85M	Buy	88,000 +18,000	+26%	+$356K	0.06%	220
2014 Q3	$1.36M	Buy	70,000 +10,000	+17%	+$157K	0.03%	345
2014 Q2	$937K	Buy	+60,000	New	+$970K	0.02%	427

Other funds holding INSY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RCM

Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Weiss Multi-Strategy Advisers's INSY Position: Q1 2019 in Review

Weiss Multi-Strategy Advisers sold out of Insys Therapeutics, Inc. (INSY) in Q1 2019, closing a stake of 35,000 shares — an estimated $123K sold.

Weiss Multi-Strategy Advisers first reported a position in INSY in Q2 2014 and held it in 19 quarters. The position peaked at $2.62M in Q1 2015. 98 funds tracked by Wall St. Rank hold INSY as of Q1 2019.

Weiss Multi-Strategy Advisers reported no remaining Insys Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 35,000 Insys Therapeutics, Inc. shares in Q1 2019, an estimated $123K.
Weiss Multi-Strategy Advisers first reported a position in Insys Therapeutics, Inc. in Q2 2014 and held it in 19 quarters.
Weiss Multi-Strategy Advisers's Insys Therapeutics, Inc. position peaked at $2.62M in Q1 2015.
98 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2019.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2019, filed 15 May 2019.